Oneness Biotech Co., Ltd. (4743.TWO)

157,00 +1,00 (+0,64%) Al cierre: 01:30PM CST

Oneness Biotech Co., Ltd.

No.236, Xinyi Road
11th Floor Sec. 4 Da’an district
Taipei 106
Taiwan
886 2 2703 1098
https://www.onenessbio.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Chih-Hui Cheng	GM & Supervisor of Corporate Governance	2,77M	N/A	N/A
Mr. Nien-Yi Chen	Deputy General Manager of Antibody New Drug Division;	6,03M	N/A	N/A
Ms. Wen-Tzu Hsiao	Acting Spokesperson & Senior Manager of Finance Department	N/A	N/A	N/A
Wen Ci Xiao	Accounting Supervisor	N/A	N/A	N/A
Dr. Jui-Ching Chen Ph.D.	Director of New Drug Development Department	N/A	N/A	N/A
Mr. Kung-Ming Lu	Director of Operation Center	N/A	N/A	N/A
Mr. Tzu-Chun Yang	Associate General Manager of Information Technology Department	2,14M	N/A	N/A

Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en TWD.

Descripción

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; OB318, an anticancer botanical drug of antrodia cinnamomea; SNS812, for the treatment of COVID-19 that is in Phase I clinical trials; and FB918 for the treatment of asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and production and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.

Gobierno corporativo

El ISS Governance QualityScore de Oneness Biotech Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.